F18 Sodium Fluoride PET Imaging: Bone Scintigraphy for Metastatic Bone Disease
Bone imaging has been around for quite some time, but it still comes with some challenges. In this video presentation, the speaker will discuss F18 NaF PET Bone imaging and how it can be incorporated in your daily clinical practice. The topics of this session include F18 NaF bone imaging in the initial assessment of potential disease and in long term care following therapy, the strengths and weaknesses of NaF bone scintigraphy in comparison to F18 FDG imaging, maximizing the utilization of PET/CT imaging to help characterize and differentiate benign from malignant disease, and how to facilitate integration of F18 NaF scintigraphy into your daily clinical environment
By the end of this session, the attendee will be able to: Describe how F18 bone imaging assists in the initial assessment of potential disease and long term care following therapy. List the strengths and weaknesses of Sodium Fluoride bone scintigraphy in comparison to F18 FDG imaging. Describe how PET/CT imaging helps to characterize and differentiate benign from malignant disease. F18 Sodium Flouride PET Imaging: Bone Scintigraphy for Metastatic Bone Disease The attendee should now be able to: Describe how F18 bone imaging assists in the initial assessment of potential disease and long term care following therapy. List the strengths and weaknesses of Sodium Fluoride bone scintigraphy in comparison to F18 FDG imaging. Describe how PET/CT imaging helps to characterize and differentiate benign from malignant disease. Select the link below to launch the video in a separate window. Webinar Video
- F18 Sodium Flouride PET Imaging
- Bone Scintigraphy for Metastatic Bone Disease